Log In
BCIQ
Print this Print this
 

Ruconest, conestat alfa (rhC1INH)

Also known as: C1 inhibitor (Rhucin)

  Manage Alerts
Collapse Summary General Information
Company Pharming Group N.V.
DescriptionRecombinant human complement 1 (C1) esterase inhibitor
Molecular Target Complement 1 (C1) esterase
Mechanism of ActionComplement 1 (C1) esterase inhibitor
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

8

$12,649.0M

$11,764.0M

$65.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today